Monivent: Funding, Investors & Team (Sep 2026)

Monivent is a young medtech startup based in Gothenburg, Sweden. Monivent aim to increase patient safety for newborn babies requiring help to start breathing at birth. 3-6% of all newborns require manual ventilation at birth, when air is manually forced down the baby’s lungs using different manual ventilation equipment. Sub‐optimal treatment, using too little or too much air, may cause brain damage or chronic lung injury. Yet there are no good tools available to ensure that an effective but still gentle treatment is given. Monivent Neo100 is a non-invasive monitoring device measuring the airflow given to the baby. Instant feedback throughout the ventilation enables the caregiver to make simple adjustments to ensure a better treatment within recommended guidelines. Monivent Neo100 is an add-on to existing manual ventilation equipment and comprises sharp technical solutions, simple interfaces and wireless data transfer for maximum ease of use and minimal impact on current practices. Monivent guides and supports the caregiver during manual ventilation of newborns to ensure a safe and gentle resuscitation with reduced risk of injury.

Monivent has raised $380k across 1 round on record. The most recent is an undisclosed round of $380k announced in Oct 2024.

Monivent's most recent funding round on record is an undisclosed round of $380k, announced in Oct 2024.

FundedIQ lists Maria Lindqvist (Founder) at Monivent.

Monivent is based in Gothenburg, Vastra Gotaland, Sweden.

Monivent is in the 11-50 employee band.

Monivent's latest round of $380k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.